Selskabsmeddelelse26.05.2024, 09.15Annual Report for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Selskabsmeddelelse30.04.2024, 10.05Cline Scientific provides an update on the company's financial position
Pressemeddelelse15.03.2024, 08.45BioStock: Scientific Advisor on the potential of Cline's cell therapy for cartilage damage
Pressemeddelelse01.03.2024, 08.30Cline: StemCART updates on achieved milestones on the way to phase 1 study
Selskabsmeddelelse23.02.2024, 08.30Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Pressemeddelelse13.02.2024, 08.30Cline Scientific advisor discusses the future of cartilage damage treatment
Selskabsmeddelelse18.01.2024, 20.12Cline Scientific provides an update on the company's financial position
Pressemeddelelse18.01.2024, 19.15Cline Scientific provides an update on the company's financial position
Pressemeddelelse22.12.2023, 12.13Cline: Medtech4Health supports capacity building in the strategy and regulatory pathway for StemCART
Pressemeddelelse08.12.2023, 12.00CORRECTION: Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future
Pressemeddelelse07.12.2023, 13.03Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future
Pressemeddelelse21.11.2023, 11.18Judgment in the market manipulation case against Cline Scientific's CEO Patrik Sundh